ATHIRA PHARMA INC (ATHA)

US04746L1044 - Common Stock

2.04  +0.07 (+3.55%)

After market: 1.99 -0.05 (-2.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
127.09M94.02M64.02M20.00M5.45M
Research and Development
93.79M61.46M42.79M13.29M3.79M
Selling, General, and Administrative Expenses
33.30M32.55M21.23M6.71M1.66M
Operating Income
-127.09M-94.02M-64.02M-20.00M-5.45M
Interest Income/Expense
N/AN/A330.00K-1.02M-370.00K
Other Income/Expense
7.79M8.38M8.84M860.00K650.00K
Non Recurring Items
1.63M-10.00M0.00200.00K0.00
Income Before Taxes
-117.67M-95.64M-54.85M-19.96M-5.16M
Net Income
-117.67M-95.64M-54.85M-19.96M-5.16M
EBITDA
-126.13M-93.17M-63.54MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-3.09-2.53-1.49-0.61-0.17
Non GAAP EPS
-3.09-2.27-1.50N/AN/A
 
Statistics

All data in USD

Charts